Hence, the classification effectiveness of ten biomarkers which was assessed overall was based on GPX2 and GPX3 as factors from the enriched pathways and CAV1, ENO1, NQO1, and P4HB as factors from functional classes to determine whether a patient had cancer. This evidence concerns the gene GPX2 and cancer.